Improving Lives Through
Diagnostic and
Therapeutic Solutions
AXIM’s proprietary research intends to find new ways to diagnose and treat cancer as well as other conditions through laboratory-derived cannabinoid and oncological therapeutics.
Improving Lives Through
Diagnostic and
Therapeutic Solutions
AXIM’s proprietary research intends to find new ways to diagnose and treat cancer as well as other conditions through laboratory-derived cannabinoid and oncological therapeutics.
COVID-19 TESTING
CLINICAL therapeutics
AXIM’s clinical therapeutic research focuses around an enzyme called “QSOX1” where the company hopes to bring a novel oncology drug to market
CANCER dIAGNOSTICS
AXIM is in development of various “point-of-care” diagnostic testing products designed for the early detection of cancer
The Latest On Our Research
AXIM® Biotechnologies Applies for FDA Emergency Use Approval (EUA) for High Throughput, Patent-Pending Neutralizing Antibody Diagnostic Test for COVID-19
SAN DIEGO, August 5, 2020 -- AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an international healthcare solutions company targeting oncological and COVID-19 research, announced today the development, patent filing and Emergency...
Making A List Of Penny Stocks Right Now? 4 Spiking This Week
By PennyStocks.com Penny Stocks To Watch: AXIM Biotechnologies Shares of AXIM Biotechnologies Inc. (AXIM Stock Report) surged earlier this month but then came swiftly back down earlier this week. Heading into the end of the week, however, we’ve noticed a move in the...
Bulls Take Charge of Axim Biotechnologies Inc (OTCMKTS: AXIM)
By Microcap Daily Axim Biotechnologies Inc (OTCMKTS: AXIM) is making a big move to the upside after the Company announced strong results for its Rapid NeuCovix™ test which was compared to a gold standard pseudovirus-based test. NeuCovix™ accurately classified serum...